Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The inhibitory effect of intravesical fisetin against bladder cancer by induction of p53 and down-regulation of NF-kappa B pathways in a rat bladder carcinogenesis model.

Li J, Qu W, Cheng Y, Sun Y, Jiang Y, Zou T, Wang Z, Xu Y, Zhao H.

Basic Clin Pharmacol Toxicol. 2014 Oct;115(4):321-9. doi: 10.1111/bcpt.12229.

2.

Chemopreventive and chemotherapeutic effects of intravesical silibinin against bladder cancer by acting on mitochondria.

Zeng J, Sun Y, Wu K, Li L, Zhang G, Yang Z, Wang Z, Zhang D, Xue Y, Chen Y, Zhu G, Wang X, He D.

Mol Cancer Ther. 2011 Jan;10(1):104-16. doi: 10.1158/1535-7163.MCT-10-0577.

3.

Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells.

Li J, Cheng Y, Qu W, Sun Y, Wang Z, Wang H, Tian B.

Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):84-93. doi: 10.1111/j.1742-7843.2010.00613.x.

4.

Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.

Zhang XJ, Jia SS.

Biomed Pharmacother. 2016 Oct;83:1164-1174. doi: 10.1016/j.biopha.2016.08.035.

PMID:
27551764
5.

Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.

Murtaza I, Adhami VM, Hafeez BB, Saleem M, Mukhtar H.

Int J Cancer. 2009 Nov 15;125(10):2465-73. doi: 10.1002/ijc.24628.

6.

A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways.

Suh Y, Afaq F, Johnson JJ, Mukhtar H.

Carcinogenesis. 2009 Feb;30(2):300-7. doi: 10.1093/carcin/bgn269.

8.

Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis.

Wang Y, Wang H, Zhang W, Shao C, Xu P, Shi CH, Shi JG, Li YM, Fu Q, Xue W, Lei YH, Gao JY, Wang JY, Gao XP, Li JQ, Yuan JL, Zhang YT.

PLoS One. 2013;8(1):e50175. doi: 10.1371/journal.pone.0050175.

9.

The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition.

Vidya Priyadarsini R, Senthil Murugan R, Maitreyi S, Ramalingam K, Karunagaran D, Nagini S.

Eur J Pharmacol. 2010 Dec 15;649(1-3):84-91. doi: 10.1016/j.ejphar.2010.09.020.

PMID:
20858478
11.

Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG.

Manikandan P, Vinothini G, Vidya Priyadarsini R, Prathiba D, Nagini S.

Invest New Drugs. 2011 Feb;29(1):110-7. doi: 10.1007/s10637-009-9345-2.

PMID:
19851710
12.
13.

PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.

Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB.

Cell Signal. 2012 Mar;24(3):726-33. doi: 10.1016/j.cellsig.2011.11.006.

PMID:
22142513
14.

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.

Li T, Zhang Q, Zhang J, Yang G, Shao Z, Luo J, Fan M, Ni C, Wu Z, Hu X.

BMC Cancer. 2014 Feb 16;14:96. doi: 10.1186/1471-2407-14-96.

15.

The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.

Szliszka E, Helewski KJ, Mizgala E, Krol W.

Int J Oncol. 2011 Oct;39(4):771-9. doi: 10.3892/ijo.2011.1116.

PMID:
21743964
16.

Melatonin enhances the anti-tumor effect of fisetin by inhibiting COX-2/iNOS and NF-κB/p300 signaling pathways.

Yi C, Zhang Y, Yu Z, Xiao Y, Wang J, Qiu H, Yu W, Tang R, Yuan Y, Guo W, Deng W.

PLoS One. 2014 Jul 7;9(7):e99943. doi: 10.1371/journal.pone.0099943.

17.

Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors.

Kamat AM, Tharakan ST, Sung B, Aggarwal BB.

Cancer Res. 2009 Dec 1;69(23):8958-66. doi: 10.1158/0008-5472.CAN-09-2045.

18.

Intravesical instillation of c-MYC inhibitor KSI-3716 suppresses orthotopic bladder tumor growth.

Jeong KC, Kim KT, Seo HH, Shin SP, Ahn KO, Ji MJ, Park WS, Kim IH, Lee SJ, Seo HK.

J Urol. 2014 Feb;191(2):510-8. doi: 10.1016/j.juro.2013.07.019.

PMID:
23872029
19.

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.

Ito Y, Kikuchi E, Tanaka N, Kosaka T, Suzuki E, Mizuno R, Shinojima T, Miyajima A, Umezawa K, Oya M.

BMC Cancer. 2015 Apr 29;15:324. doi: 10.1186/s12885-015-1315-9.

20.

Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model.

Steinberg GD, Brendler CB, Squire RA, Isaacs JT.

J Urol. 1991 Mar;145(3):647-53.

PMID:
1997724

Supplemental Content

Support Center